Browsing by Keyword : Neutropenia
Showing results 1 to 10 of 10
| Pub Year | | Title | AJOU Author(s) |
| 2017 | | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 박준성, 정성현 |
| 2013 | | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. | 강석윤 |
| 2018 | | Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study | 강석윤, 이현우 |
| 2018 | | Can early removal of central venous catheter influence duration of fever in febrile neutropenic patients with acute myeloid leukemia? | 김태환, 박준성 |
| 2023 | | Clinically differential diagnosis of human granulocytic anaplasmosis and severe fever with thrombocytopenia syndrome | 허중연 |
| 2014 | | Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT. | 박준은 |
| 2016 | | Mesenteric vasculitis after G-CSF administration in a severe neutropenic patient with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2017 | | Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia | 박준성 |
| 2011 | | Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia. | 박준성 |
1
